What is the safety of expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion?
According to the study by Wu et al. (2006), expedited anticoagulation in patients undergoing transesophageal echocardiographic-guided cardioversion was found to be safe. The study concluded that there were no in-hospital major adverse events related to anticoagulation in the patients studied, and that the use of enoxaparin for anticoagulation resulted in no significant difference in the incidence of thromboembolic complications compared to unfractionated heparin.